Position in ETON
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$705,067
+$552,031 QoQ
Shares Held
19,477
-30.6% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 163 holders
Holding Since
Mar 2020
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. ETON ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in ETON
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $705,067 | 19,477 | Shares | Sole | 2026-08-11 | |
| 2020-06-30 | $153,036 | 28,080 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $82,996 | 20,243 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||